Almoxatone

This classification denotes a monoamine oxidase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 85V47MCE4Z. European Medicines Agency schedules Almoxatone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05351MIG. Almoxatone generally arises in the molecular formula C18H19CLN2O3. The term ALMOXATONE is an International Non-Proprietary Name or INN. ALMOXATONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule almoxatone under HS 29349990 and SITC 51579. As of Q4 2014, ALMOXATONE remains the US FDA Preferred Term for this commodity. Almoxatone bears US NLM identifiers UMLS ID C2348428 and NCI Concept Code C72688. SMILES: Clc1cc(COc2ccc(N3CC(OC3=O)CNC)cc2)ccc1.